Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Los Angeles, CA, March 27, 2026 (GLOBE NEWSWIRE) -- BuffHub, gaming top-up platform, announced the release of its 2026 mobile gaming insights, highlighting a significant shift in Gen Z player...
-
Gym Plus has expanded its all-in-one functional trainer range with System X, Oasis, and the Evolve Power Rack with Dual Pin-loaded Rack Mount Cable System, offering compact, versatile...
-
First Patient Dosed (FPD) in Phase 2a MAINSAIL Trial of NAV-240 in Hidradenitis Suppurativa (HS)Phase 1b Multiple Ascending Dose Study Demonstrates Favorable Profile for NAV-240 First Participant...
-
WINTER PARK, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX) today issued a statement to clarify and formally refute a series of third-party...
-
BARTLETT, Tenn., March 26, 2026 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG) (“SurgePays” or the “Company”), a wireless and fintech technology company serving subprime and underserved...
-
Milestone announcement at SAGES 2026 underscores accelerating adoption of Versius as CMR prepares for U.S. expansion following recent FDA clearance CAMBRIDGE, UK and TAMPA, FL – March 26, 2026 — CMR...
-
Dynacor Group Inc. (TSX: DNG) today announced its financial and operational results for the year and quarter ended December 31, 2025.
-
– Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen in broad patient populations in both severe asthma and CRSwNP – –...
-
URBANICA expands nationwide access to Novo and Onyx ergonomic chairs for home office upgrades, offering two price tiers, free shipping, and warranties.
-
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi™ generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 ...